Vertex Pharmaceuticals gets grant for treatment of alpha-1 antitrypsin deficiency with compound of formula (i)

Discover Vertex Pharmaceuticals' groundbreaking patent for compounds treating alpha-1 antitrypsin deficiency. Explore formula (I) derivatives and tailored compositions for precision medicine.

Related Posts

STAT+: New mega-deal highlights Geisinger’s fall, and r...

May 1, 2023

STAT+: Trade group scolds drugmaker for ‘unethical’ att...

Jun 16, 2023

AnGes files patent for crispr-based method for modifyin...

Mar 24, 2024